MedTrace Logo

Mucus Solids Concentration in Patients With Bronchiectasis

NCT04310618 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-10-01

No results posted yet for this study

Summary

There is a need for biomarkers that can rapidly and sensitively detect therapeutic benefits of therapies designed to "rehydrate" airways and monitor disease severity and progression. In this study the investigators will evaluate the stability of mucus concentration in patients with bronquiectasis (CF and NCBF) and its ability to respond to acute exacerbations in order to assess whether it can be a good candidate for biomarker.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Asociación Murciana de Fibrosis Quistica

    collaborator UNKNOWN

  • University of North Carolina

    collaborator OTHER

  • Universidad San Jorge

    lead OTHER

Principal Investigators

  • Marta San Miguel Pagola · Universidad San Jorge

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2023-03-31
Completion
2023-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310618 on ClinicalTrials.gov